计算溶液所需的质量、体积或浓度。
JMV7048 is an effective PROTAC degrader targeting PXR (Pregnane X Receptor) with a DC 50 of 379 nM. JMV7048 induces the polyubiquitination and degradation of PXR protein by recruiting E3 CRBN ubiquitin ligase and the 26S proteasome. JMV7048 significantly enhances the sensitivity of colon cancer stem cells to chemotherapy by reducing the expression of PXR protein in these cells, thereby significantly delaying cancer recurrence in vivo. JMV7048 is composed of the PXR agonist JMV6944 , linker , and Thalidomide 5-fluoride (Red: JMV6944 ; Blue: Thalidomide 5-fluoride ligand; Black: linker).